These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 25653121)

  • 1. Cost-effectiveness analysis of malaria rapid diagnostic test incentive schemes for informal private healthcare providers in Myanmar.
    Chen IT; Aung T; Thant HN; Sudhinaraset M; Kahn JG
    Malar J; 2015 Feb; 14():55. PubMed ID: 25653121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improving uptake and use of malaria rapid diagnostic tests in the context of artemisinin drug resistance containment in eastern Myanmar: an evaluation of incentive schemes among informal private healthcare providers.
    Aung T; White C; Montagu D; McFarland W; Hlaing T; Khin HS; San AK; Briegleb C; Chen I; Sudhinaraset M
    Malar J; 2015 Mar; 14():105. PubMed ID: 25885581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subsidising artemisinin-based combination therapy in the private retail sector.
    Opiyo N; Yamey G; Garner P
    Cochrane Database Syst Rev; 2016 Mar; 3(3):CD009926. PubMed ID: 26954551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness analysis of rapid diagnostic test, microscopy and syndromic approach in the diagnosis of malaria in Nigeria: implications for scaling-up deployment of ACT.
    Uzochukwu BS; Obikeze EN; Onwujekwe OE; Onoka CA; Griffiths UK
    Malar J; 2009 Nov; 8():265. PubMed ID: 19930666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Motivation and challenges for use of malaria rapid diagnostic tests among informal providers in Myanmar: a qualitative study.
    Sudhinaraset M; Briegleb C; Aung M; Khin HS; Aung T
    Malar J; 2015 Feb; 14():61. PubMed ID: 25889046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of diagnostic for malaria in Extra-Amazon Region, Brazil.
    de Oliveira MR; Giozza SP; Peixoto HM; Romero GA
    Malar J; 2012 Nov; 11():390. PubMed ID: 23176717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of malaria diagnostic methods in sub-Saharan Africa in an era of combination therapy.
    Shillcutt S; Morel C; Goodman C; Coleman P; Bell D; Whitty CJ; Mills A
    Bull World Health Organ; 2008 Feb; 86(2):101-10. PubMed ID: 18297164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of district-wide seasonal malaria chemoprevention when implemented through routine malaria control programme in Kita, Mali using fixed point distribution.
    Diawara H; Walker P; Cairns M; Steinhardt LC; Diawara F; Kamate B; Duval L; Sicuri E; Sagara I; Sadou A; Mihigo J; Eckert E; Dicko A; Conteh L
    Malar J; 2021 Mar; 20(1):128. PubMed ID: 33663488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The private sector market for malaria rapid diagnostic tests in Nigeria: results of the 2018 market survey.
    Edwards HM; Sarwar R; Mahmud P; Emmanuel S; Maxwell K; Tibenderana JK
    Malar J; 2022 Jun; 21(1):190. PubMed ID: 35710474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Private sector opportunities and threats to achieving malaria elimination in the Greater Mekong Subregion: results from malaria outlet surveys in Cambodia, the Lao PDR, Myanmar, and Thailand.
    ; Phok S; Phanalasy S; Thein ST; Likhitsup A
    Malar J; 2017 May; 16(1):180. PubMed ID: 28464945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Achieving malaria testing and treatment targets for children under five in Mozambique: a cost-effectiveness analysis.
    Avanceña ALV; Miller A; Canana N; Dula J; Saifodine A; Cadrinho B; Maffioli EM
    Malar J; 2022 Nov; 21(1):320. PubMed ID: 36344998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modelling the cost-effectiveness of introducing subsidised malaria rapid diagnostic tests in the private retail sector in sub-Saharan Africa.
    Bath D; Goodman C; Yeung S
    BMJ Glob Health; 2020 May; 5(5):. PubMed ID: 32439690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Availability and quality of anti-malarials among private sector outlets in Myanmar in 2012: results from a large, community-based, cross-sectional survey before a large-scale intervention.
    Khin HS; Chen I; White C; Sudhinaraset M; McFarland W; Littrell M; Montagu D; Aung T
    Malar J; 2015 Jul; 14():269. PubMed ID: 26169498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimal price subsidies for appropriate malaria testing and treatment behaviour.
    Hansen KS; Lesner TH; Østerdal LP
    Malar J; 2016 Nov; 15(1):534. PubMed ID: 27814767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Towards subsidized malaria rapid diagnostic tests. Lessons learned from programmes to subsidise artemisinin-based combination therapies in the private sector: a review.
    Lussiana C
    Health Policy Plan; 2016 Sep; 31(7):928-39. PubMed ID: 25862732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of interventions for HIV/AIDS, malaria, syphilis, and tuberculosis in 128 countries: a meta-regression analysis.
    Silke F; Earl L; Hsu J; Janko MM; Joffe J; Memetova A; Michael D; Zheng P; Aravkin A; Murray CJL; Weaver MR
    Lancet Glob Health; 2024 Jul; 12(7):e1159-e1173. PubMed ID: 38876762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioeconomic analysis of child-targeted subsidies for artemisinin combination therapies: a cost-effectiveness analysis.
    Klein EY; Smith DL; Cohen JM; Laxminarayan R
    J R Soc Interface; 2015 Jun; 12(107):. PubMed ID: 25994293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral artemisinin monotherapy removal from the private sector in Eastern Myanmar between 2012 and 2014.
    Khin HS; Aung T; Thi A; White C;
    Malar J; 2016 May; 15(1):286. PubMed ID: 27216408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Costing electronic private sector malaria surveillance in the Greater Mekong Subregion.
    Levin A; Potter R; Tesfazghi K; Phanalangsy S; Keo P; Filip E; Phone SH; Eliades MJ
    Malar J; 2021 Apr; 20(1):192. PubMed ID: 33879159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.